Patients with possible or suspected ALS (22.5 ± 5.2 ng/mL) had significantly higher CSF NSE levels than those with definite, probable, or PLS ALS (19.5 ± 4.5 ng/mL, P = 0.046). The gene discussed is ENO2; the disease is amyotrophic lateral sclerosis.